China Oceanwide Committed to Putting More Money into Genworth

Regulators in New York became favorably disposed to China Oceanwide’s acquisition of Genworth after the buyer committed to significantly increase its financial commitment, accordingfeatured

Stillwater Mining/Sibanye Review Extended by CFIUS

With additional reporting by Diane Alter and Valeria Camerino – The review of the proposed acquisition of Stillwater Mining, the US’s only producer of platinum and palladium,featured

Experts See MoneyGram/Ant Financial Deal Clearing CFIUS with Heavy Scrutiny

A former policy adviser to the National Security Council told CTFN that the acquisition of MoneyGram by Ant Financial raises critical concerns around data privacy, data protection, andfeatured

Election Not Grounds for CFIUS Re-Examination of Syngenta/ChemChina

With additional reporting by Sarah Cohen and Diane Alter – The Committee on Foreign Investment in the United States cannot re-examine ChemChina’s $43 billion purchase of Syngenta of Switzerland merely because Donald Trump, a Republican, willfeatured

Genworth-China Oceanwide Deal in Doubt

The likelihood that regulators will approve China Oceanwide Holdings’ $2.7 billion, or $5.43 per share, acquisition of Genworth Financial is slim, several attorneys told CTFN. “I don’t see this deal happening no way and no how,” an insurance regulatory attorney close to Genworth said. “This is evenfeatured

Regulators Could Take a Year to Decide Renesas/Intersil Remedies

If remedies are necessary to safeguard Intersil’s facility in Palm Bay, Florida, where it manufactures chips for defense purposes, regulators including the Committee on Foreign Investment in the United States and the Defense Security Service are likely to take between three months to a year to decide the site’s fate, two sector lawyers told CTFN. … Read Morefeatured

Ingram Micro’s Federal Business May Not Require Sale

In the event that the Committee on Foreign Investment in the United States demands that Ingram Micro divest its federal business to proceed with its takeout by Tianjin Tianhai/HNA Group, the remedy might be as simple as terminating contracts, and need not require the sale of a business, suggested sources in the distribution, legal, and … Read Morefeatured

Syngenta/ChemChina Merger Hinges on US Approval

The outcome of the planned $43 billion merger between Swiss biotech giant Syngenta and chemical conglomerate ChemChina will mainly depend on whether the parties receive US blessing for the deal, three lawyers familiar with the industry told CTFN. Henning Schneider, co-chair of the German Corporate Department and chair of the global Healthcare Industry Group at … Read Morefeatured

States Begin Review Process in ITC/Fortis Combination

Utility industry observers in Canada and the U.S. say they do not expect significant regulatory problems to surface at either the federal or state levels in Fortis’ $11.3 billion bid to acquire ITC Holdings. “I wouldn’t anticipate there will be much pushback on this,” Guy Holburn, director of the Ivey Energy Policy and Managementfeatured

Ingram Micro Spread Stays Wide as Chinese Regulatory Adds to CFIUS Worries

Ingram Micro trades 11% below Tianjin Tianhai’s offer of $38.90 per share on fears that Chinese and US regulators could delay or unravel the transaction, sources said. Though concerns over Ingram and Tianjin Tianhai’s decision to file notice to the Committee on Foreign Investment in the Unitedfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.